COCHLEAR ORD
Weekly wrap: ASX loses steam amid hairy chested war rhetoric
ASX slips as Trump-Iran tension persists; IGO sinks 18% on lithium gloom, while energy stocks rally; weekly loss about 1.8%.
Cochlear rejects ACCC’s concerns over Oticon Medical acquisition, Santos loses Barossa offshore drilling appeal and Beach Energy submits counterproposal
Australia’s competition watchdog, the Australian Competition and Consumer Commission (ACCC) declared it has “significant preliminary competition concerns” regarding Cochlear’s (ASX: COH) proposed $170 million acquisition of Oticon Medical. Cochlear and Oticon Medical manufacture and distribute non-surgical bone conduction devices, surgical bone anchored devices, and cochlear implant hearing devices. The ACCC released a statement fearing the […]
COVID-19 pandemic hits Cochlear and Suncorp
The COVID-19 pandemic has continued to have a big impact on Australian companies, with the latest being Cochlear (ASX: COH) and Suncorp (ASX: SUN). Cochlear chief executive officer Dig Howitt said it was still too early to predict the true impact of coronavirus on the hearing implant maker, which is in “unchartered territory” due to […]